Antiemetics Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning.
Portland, OR -- (SBWire) -- 07/18/2017 --In-depth discussion of global Antiemetics Market includes past and current trends with future forecast up to 2020. Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision making process. The report is informative towards geographical segmentation and identifies profitable areas.
However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization. Moreover, lack of suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share.
Get sample of the Report : https://www.alliedmarketresearch.com/request-toc-and-sample/435
KEY DELIVERABLES
The global antiemetic drugs market is segmented into three major categories such as type, application and geography.
MARKET BY TYPE
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- Others
MARKET BY APPLICATION
- Chemotherapy
- Motion sickness
- Gastroenteritis
- General anesthetics
- Opioid analgesics
- Dizziness
- Pregnancy
- Food poisoning
- Emotional stress
- Others
MARKET BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
- LAMEA
Early buyers will receive 20% customization on this report
Media Relations Contact
Allied Market Research
800-792-5285
https://www.alliedmarketresearch.com
View this press release online at: http://rwire.com/834585